.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J04A_DrugsForTreatmentOfTuberculosis.J04AC01_Isoniazid.Isoniazid .Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J04A_DrugsForTreatmentOfTuberculosis.J04AC01_Isoniazid.Isoniazid| name: | Isoniazid |
| ATC code: | J04AC01 | route: | oral |
| n-compartments | 1 |
Isoniazid is a bactericidal antibiotic used primarily as a first-line agent for the prevention and treatment of tuberculosis. It is generally approved and used today, often in combination with other antitubercular medications.
Pharmacokinetic parameters reported for healthy adult volunteers, both sexes, after single oral dose.
Chen, B, et al., & Cai, WM (2022). Population Pharmacokinetics and Pharmacodynamics of Isoniazid and its Metabolite Acetylisoniazid in Chinese Population. Frontiers in pharmacology 13 932686–None. DOI:10.3389/fphar.2022.932686 PUBMED:https://pubmed.ncbi.nlm.nih.gov/35928262
Sullins, AK, & Abdel-Rahman, SM (2013). Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. Paediatric drugs 15(2) 93–117. DOI:10.1007/s40272-013-0017-5 PUBMED:https://pubmed.ncbi.nlm.nih.gov/23529866
Wilkins, JJ, et al., & Simonsson, US (2011). Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients. British journal of clinical pharmacology 72(1) 51–62. DOI:10.1111/j.1365-2125.2011.03940.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/21320152